Longevity Technology: 'Juvenescence CEO on near-term Longevity breakthroughs

Dr. Gregory Bailey, MD gives an interview to Longevity Technology on near-term longevity breakthroughs, including the latest developments at Juvenescence and dealing with the impact of COVID-19.

Dr. Bailey discusses Juvenescence’s plans to bring on a completely new mechanism for regeneration and how that plan is coming to life through its JuvRegeneration division – specifically through partners LyGenesis and AgeX Therapeutics.

He also discusses Juvenescence’s Q3 product launch of a direct-to-consumer ketone di-ester drink product that is geroprotective, neuroprotective and cardioprotective.

Read the full article at Longevity Technology.